Long Noncoding RNA GUSBP11 Knockdown Alleviates Nasopharyngeal Carcinoma via Regulating miR-1226-3p/TM9SF4 Axis.

IF 3.2 3区 医学 Q2 PHARMACOLOGY & PHARMACY
Molecular Pharmacology Pub Date : 2024-03-01 Epub Date: 2022-06-08 DOI:10.1089/cbr.2021.0391
Xiaofeng Zhang, Jinzhi Liu, MengMeng Ji, GuiQin Qi, Renling Qiao
{"title":"Long Noncoding RNA GUSBP11 Knockdown Alleviates Nasopharyngeal Carcinoma via Regulating miR-1226-3p/<i>TM9SF4</i> Axis.","authors":"Xiaofeng Zhang, Jinzhi Liu, MengMeng Ji, GuiQin Qi, Renling Qiao","doi":"10.1089/cbr.2021.0391","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Purpose:</i></b> Long noncoding RNAs (lncRNAs) have been confirmed related to the occurrence and progress of multiple cancers, including cervical cancer nasopharyngeal carcinoma (NPC). This study focused on assessing GUSBP11 effects on NPC progression and exploring possible mechanisms. <b><i>Materials and Methods:</i></b> RT-qPCR was conducted for assessing GUSBP11 levels within NPC tissues and cells. CCK-8, colony formation, and Transwell were adopted for examining GUSBP11 impacts on NPC cell proliferation and cell metastasis. RT-qPCR analysis and dual-luciferase reporter assay were conducted for judging the expression interrelation of GUSBP11 and its potential target miR-1226-3p. The same methods were carried out for verifying the inhibiting influences of miR-1226-3p upregulation and its potential target <i>TM9SF4</i>. <b><i>Results:</i></b> GUSBP11 levels were upregulated within NPC tissues and cells. GUSBP11 downregulation repressed NPC cell proliferation and cell metastasis. In addition, GUSBP11 targeted and negatively regulated miR-1226-3p. Furthermore, miR-1226-3p targeted <i>TM9SF4</i> and mediated GUSBP11's impacts on <i>TM9SF4</i> levels. At last, the authors proved the critical role of the GUSBP11/miR-1226-3p/TM9SF4 axis in regulating NPC progression. <b><i>Conclusion</i>:</b> These findings indicate that downregulation of GUSBP11 alleviates NPC development by regulating the miR-1226-3p/<i>TM9SF4</i> axis.</p>","PeriodicalId":18767,"journal":{"name":"Molecular Pharmacology","volume":"60 5 1","pages":"133-143"},"PeriodicalIF":3.2000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/cbr.2021.0391","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/6/8 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Long noncoding RNAs (lncRNAs) have been confirmed related to the occurrence and progress of multiple cancers, including cervical cancer nasopharyngeal carcinoma (NPC). This study focused on assessing GUSBP11 effects on NPC progression and exploring possible mechanisms. Materials and Methods: RT-qPCR was conducted for assessing GUSBP11 levels within NPC tissues and cells. CCK-8, colony formation, and Transwell were adopted for examining GUSBP11 impacts on NPC cell proliferation and cell metastasis. RT-qPCR analysis and dual-luciferase reporter assay were conducted for judging the expression interrelation of GUSBP11 and its potential target miR-1226-3p. The same methods were carried out for verifying the inhibiting influences of miR-1226-3p upregulation and its potential target TM9SF4. Results: GUSBP11 levels were upregulated within NPC tissues and cells. GUSBP11 downregulation repressed NPC cell proliferation and cell metastasis. In addition, GUSBP11 targeted and negatively regulated miR-1226-3p. Furthermore, miR-1226-3p targeted TM9SF4 and mediated GUSBP11's impacts on TM9SF4 levels. At last, the authors proved the critical role of the GUSBP11/miR-1226-3p/TM9SF4 axis in regulating NPC progression. Conclusion: These findings indicate that downregulation of GUSBP11 alleviates NPC development by regulating the miR-1226-3p/TM9SF4 axis.

长非编码 RNA GUSBP11 基因敲除通过调控 miR-1226-3p/TM9SF4 轴减轻鼻咽癌病情
目的:长非编码RNA(lncRNA)已被证实与多种癌症的发生和进展有关,包括宫颈癌鼻咽癌(NPC)。本研究的重点是评估 GUSBP11 对鼻咽癌进展的影响并探索可能的机制。材料与方法:采用 RT-qPCR 评估鼻咽癌组织和细胞中的 GUSBP11 水平。采用 CCK-8、集落形成和 Transwell 等方法检测 GUSBP11 对鼻咽癌细胞增殖和细胞转移的影响。通过 RT-qPCR 分析和双荧光素酶报告实验来判断 GUSBP11 及其潜在靶标 miR-1226-3p 的表达相互关系。用同样的方法验证了 miR-1226-3p 的上调及其潜在靶标 TM9SF4 的抑制作用。结果鼻咽癌组织和细胞中 GUSBP11 水平上调。下调 GUSBP11 可抑制鼻咽癌细胞的增殖和转移。此外,GUSBP11靶向负调控miR-1226-3p。此外,miR-1226-3p 靶向 TM9SF4,并介导 GUSBP11 对 TM9SF4 水平的影响。最后,作者证明了 GUSBP11/miR-1226-3p/TM9SF4 轴在调控鼻咽癌进展中的关键作用。结论这些研究结果表明,下调 GUSBP11 可通过调节 miR-1226-3p/TM9SF4 轴缓解鼻咽癌的发展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Molecular Pharmacology
Molecular Pharmacology 医学-药学
CiteScore
7.20
自引率
2.80%
发文量
50
审稿时长
3-6 weeks
期刊介绍: Molecular Pharmacology publishes findings derived from the application of innovative structural biology, biochemistry, biophysics, physiology, genetics, and molecular biology to basic pharmacological problems that provide mechanistic insights that are broadly important for the fields of pharmacology and toxicology. Relevant topics include: Molecular Signaling / Mechanism of Drug Action Chemical Biology / Drug Discovery Structure of Drug-Receptor Complex Systems Analysis of Drug Action Drug Transport / Metabolism
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信